Heart Failure News

News

Old Antidepressant Offers Promise In Treating Heart Failure - 01/05/2010
www.hopkinsmedicine.org | Jan 27, 2012
A team of Johns Hopkins and other researchers have found in animal experiments that an antidepressant developed over 40 years ago can blunt and even reverse the muscle enlargement and weakened pumping function associated with heart failure.

Viagra against heart failure: Researchers at the RUB and from Rochester throw light on the mechanism
www.eurekalert.org | Dec 26, 2011
How sildenafil, the active ingredient in Viagra, can alleviate heart problems is reported by Bochum's researchers in cooperation with colleagues from the Mayo Clinic in Rochester (Minnesota) in the journal Circulation. They studied dogs with diastolic heart failure, a condition in which the heart

Nile Therapeutics Inc Announces Top Line Results
www.biospace.com | Nov 16, 2011
SAN MATEO, Calif., Nov. 16, 2011 /PRNewswire/ -- Nile Therapeutics, Inc. , a biopharmaceutical company that develops novel therapeutics for heart

Studies: Stem cells reverse heart damage - CNN.com
www.cnn.com | Nov 16, 2011
Recent studies done by Cedars-Sinai Medical Center in Los Angeles show that stem cell treatments can reverse heart damage.

Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018 | PRLog
www.prlog.org | Nov 10, 2011
Heart Failure (HF) Therapeutics - Pipeline Assessment and Market Forecasts to 2018. The HF Therapeutics Market Shows Significant Growth Until 2018 - PR11720407

eplerenone | Study shows eplerenone significantly reduced the incidence of new onset atrial
www.pharmaasia.com | Sep 13, 2011
• Study also reveals that eplerenone reduces risk of death and the risk of hospitalization among patients with systolic heart failure and mild symptoms.

Hospital deaths from heart failure slashed in half - FierceHealthcare
www.fiercehealthcare.com | Aug 26, 2011
Hospital deaths from health failure were cut in half between 2000 and 2007, from 55 deaths to 28 deaths per 1,000 admissions, according to Agency for Healthcare Research and Quality statistics Read more...

Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients
eurjhf.oxfordjournals.org | Aug 3, 2011
Eur J Heart Failure (Drechsler et al): Conclusion Low homoarginine is a strong risk factor for SCD and death due to heart failure in haemodialysis patients. Further studies are needed to elucidate the underlying mechanisms, offering the potential to develop new interventional strategies.

Allegheny General Hospital Heart Transplant Program Has Best Patient Outcomes in Pennsylvania
www.prweb.com | Jul 27, 2011
Just recognized by U.S. News and World Report Magazine as one of the country's preeminent centers for the treatment of heart disease, Pittsburgh's Allegheny General Hospital also boasts the state of Pennsylvania's highest quality heart transplant program, according a new national report

Cytokinetics' Promising Pipeline: Value Stock for a Long-Term Investor - Seeking Alpha
seekingalpha.com | Jul 20, 2011
< strong > By < a href='http://seekingalpha.com/author/j-p-zaragoza' > J.P. Zaragoza < /a > : < /strong > < p > Throughout this year, Cytokinetics’ ( < a href='http://seekingalpha.com/symbol/cytk' title='Cytokinetics, Incorporated' > CYTK < /a > ) shares have been moving between $1.12 and $2.96.